Status:

COMPLETED

A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Controlled Ovarian Hyperstimulation

Lead Sponsor:

Merck KGaA, Darmstadt, Germany

Conditions:

Infertility

Eligibility:

FEMALE

20-43 years

Brief Summary

This is a phase IV non-interventional, multicentric observational study to evaluate the baseline follicle stimulating hormone (FSH) levels, ovarian volume, antral follicle count (AFC) and age as progn...

Detailed Description

Treatment of subfertility and infertility by assisted reproduction technologies (ART) such as IVF and embryo transfer (ET) requires multiple follicular development to increase the number of female gam...

Eligibility Criteria

Inclusion

  • Pre-menopausal female subjects aged between 20-43 years
  • Subjects requiring treatment with recombinant FSH for COH for IVF and/or ICSI
  • Subjects who are able to communicate well with the investigator and can comply with the requirements of the entire study
  • Subjects who have given written informed consent, prior to treatment, with the understanding that consent may be withdrawn by the subject at any time without prejudice

Exclusion

  • Female subjects not pregnant or lactating
  • Subjects with known allergic reaction against one of the ingredients
  • Subjects with enlarged ovaries or cysts unrelated to polycystic ovarian disease.
  • Subjects with gynaecological bleeding of unknown origin
  • Subjects with ovarian, uterine, or mammary cancer
  • Subjects with hyperprolactinaemia
  • Subjects with tumors of the hypothalamus or the pituitary gland

Key Trial Info

Start Date :

October 1 2008

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 1 2011

Estimated Enrollment :

356 Patients enrolled

Trial Details

Trial ID

NCT01196143

Start Date

October 1 2008

End Date

January 1 2011

Last Update

February 4 2014

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre of Assisted Reproduction "Embryoland"

Athens, Greece, 11 523

A Study to Evaluate the Baseline Follicle Stimulating Hormone, Ovarian Volume and Antral Follicle Count as Prognostic Factors of the Outcome of In-vitro Fertilisation/Intracytosolic Sperm Injection in Infertile Patients Receiving Gonal f for Controlled Ovarian Hyperstimulation | DecenTrialz